Techne Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Bio-Techne Corp DRC (T1CH34)
Bio-Techne Corp DRC stock price live, this page displays BVMF T1CH34 stock exchange data. View the T1CH34 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Bio-Techne Corp DRC real time stock price chart below.
What Is the Bio-Techne Corp DRC Stock Price Today?
The Bio-Techne Corp DRC stock price today is 12.18.
What Is the Stock Symbol for Bio-Techne Corp DRC?
The stock symbol for Bio-Techne Corp DRC is "T1CH34."
What Stock Exchange Does Bio-Techne Corp DRC Trade On?
Bio-Techne Corp DRC is listed and trades on the B3 stock exchange.
Is Bio-Techne Corp DRC a Good Stock to Buy?
Determining whether Bio-Techne Corp DRC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the T1CH34 quote. (ISIN: BRT1CHBDR003)
What Is the Bio-Techne Corp DRC Stock Price Today?
The Bio-Techne Corp DRC stock price today is 12.18.
What Is the Stock Symbol for Bio-Techne Corp DRC?
The stock symbol for Bio-Techne Corp DRC is "T1CH34."
What Stock Exchange Does Bio-Techne Corp DRC Trade On?
Bio-Techne Corp DRC is listed and trades on the B3 stock exchange.
Is Bio-Techne Corp DRC a Good Stock to Buy?
Determining whether Bio-Techne Corp DRC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the T1CH34 quote. (ISIN: BRT1CHBDR003)
12.18
-0.02(-0.16%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
12.18
12.18
52 wk Range
7.34
12.57
T1CH34 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
12.1812.18
52 wk Range
7.3412.57
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.30%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.30%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
T1CH34 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in overbought territory
- Techne Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Techne Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Techne Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Techne Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Techne Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Earnings
Latest Release
May 06, 2026
EPS / Forecast
0.32 / --
Revenue / Forecast
311.42M / --
Compare T1CH34 to Peers and Sector
Metrics to compare | T1CH34 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipT1CH34PeersSector | |
|---|---|---|---|---|
P/E Ratio | 101.6x | 25.9x | −0.4x | |
PEG Ratio | −6.20 | 0.21 | 0.00 | |
Price/Book | 5.3x | 2.4x | 2.6x | |
Price / LTM Sales | 9.2x | 3.4x | 3.0x | |
Upside (Analyst Target) | - | 11.6% | 56.9% | |
Fair Value Upside | Unlock | 10.0% | 9.3% | Unlock |
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the BioTechne (T1CH34) Stock Price Today?
The BioTechne stock price today is 12.18 BRL.
What Stock Exchange Does BioTechne Trade On?
BioTechne is listed and trades on the B3 Stock Exchange.
What Is the Stock Symbol for BioTechne?
The stock symbol for BioTechne is "T1CH34."
Does BioTechne Pay Dividends? What’s The Current Dividend Yield?
The BioTechne dividend yield is 0.3%.
What Is the BioTechne Market Cap?
As of today, BioTechne market cap is 57.22B BRL.
What Is BioTechne's Earnings Per Share (TTM)?
The BioTechne EPS (TTM) is 0.69.
From a Technical Analysis Perspective, Is T1CH34 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has BioTechne Stock Split?
BioTechne has split 1 times.
How Many Employees Does BioTechne Have?
BioTechne has 3100 employees.
What is the current trading status of BioTechne (T1CH34)?
As of Jun 27, 2026, BioTechne (T1CH34) is trading at a price of 12.18 BRL, with a previous close of 12.20 BRL. The stock has fluctuated within a day range of 12.18 BRL to 12.18 BRL, while its 52-week range spans from 7.34 BRL to 12.57 BRL.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.